Global Schizophrenia Drugs Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Schizophrenia Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Schizophrenia Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Schizophrenia Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. 

Globally, Schizophrenia Drugs key manufacturers include Johnson & Johnson, Bristol-Myers Squibb, Otsuka Pharma, AstraZeneca, Sumitomo Dainippon, Eli Lilly, Alkermes, Vanda Pharma and Allergan, etc. Johnson & Johnson, Bristol-Myers Squibb, Otsuka Pharma are top 3 players and held % sales share in total in 2022.

Schizophrenia Drugs can be divided into Oral Antipsychotics and Injectable Antipsychotics, etc. Oral Antipsychotics is the mainstream product in the market, accounting for % sales share globally in 2022.

Schizophrenia Drugs is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Schizophrenia Drugs industry development. In 2022, global % sales of Schizophrenia Drugs went into Hospital filed. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Schizophrenia Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    Johnson & Johnson
    Bristol-Myers Squibb
    Otsuka Pharma
    AstraZeneca
    Sumitomo Dainippon
    Eli Lilly
    Alkermes
    Vanda Pharma
    Allergan
    Pfizer

Segment by Type
    Oral Antipsychotics
    Injectable Antipsychotics

Segment by Application
    Hospital
    Clinic

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Schizophrenia Drugs market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Schizophrenia Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Schizophrenia Drugs industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Schizophrenia Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Schizophrenia Drugs introduction, etc. Schizophrenia Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Schizophrenia Drugs market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Schizophrenia Drugs Market Overview
    1.1 Schizophrenia Drugs Product Overview
    1.2 Schizophrenia Drugs Market Segment by Type
        1.2.1 Oral Antipsychotics
        1.2.2 Injectable Antipsychotics
    1.3 Global Schizophrenia Drugs Market Size by Type
        1.3.1 Global Schizophrenia Drugs Market Size Overview by Type (2018-2029)
        1.3.2 Global Schizophrenia Drugs Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Schizophrenia Drugs Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Schizophrenia Drugs Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Schizophrenia Drugs Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Schizophrenia Drugs Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Schizophrenia Drugs Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Schizophrenia Drugs Sales Breakdown by Type (2018-2023)

 2 Global Schizophrenia Drugs Market Competition by Company
    2.1 Global Top Players by Schizophrenia Drugs Sales (2018-2023)
    2.2 Global Top Players by Schizophrenia Drugs Revenue (2018-2023)
    2.3 Global Top Players by Schizophrenia Drugs Price (2018-2023)
    2.4 Global Top Manufacturers Schizophrenia Drugs Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Schizophrenia Drugs Market Competitive Situation and Trends
        2.5.1 Schizophrenia Drugs Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Schizophrenia Drugs Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Schizophrenia Drugs as of 2022)
    2.7 Date of Key Manufacturers Enter into Schizophrenia Drugs Market
    2.8 Key Manufacturers Schizophrenia Drugs Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Schizophrenia Drugs Status and Outlook by Region
    3.1 Global Schizophrenia Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Schizophrenia Drugs Historic Market Size by Region
        3.2.1 Global Schizophrenia Drugs Sales in Volume by Region (2018-2023)
        3.2.2 Global Schizophrenia Drugs Sales in Value by Region (2018-2023)
        3.2.3 Global Schizophrenia Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Schizophrenia Drugs Forecasted Market Size by Region
        3.3.1 Global Schizophrenia Drugs Sales in Volume by Region (2024-2029)
        3.3.2 Global Schizophrenia Drugs Sales in Value by Region (2024-2029)
        3.3.3 Global Schizophrenia Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Schizophrenia Drugs by Application
    4.1 Schizophrenia Drugs Market Segment by Application
        4.1.1 Hospital
        4.1.2 Clinic
    4.2 Global Schizophrenia Drugs Market Size by Application
        4.2.1 Global Schizophrenia Drugs Market Size Overview by Application (2018-2029)
        4.2.2 Global Schizophrenia Drugs Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Schizophrenia Drugs Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Schizophrenia Drugs Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Schizophrenia Drugs Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Schizophrenia Drugs Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Schizophrenia Drugs Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Schizophrenia Drugs Sales Breakdown by Application (2018-2023)

 5 North America Schizophrenia Drugs by Country
    5.1 North America Schizophrenia Drugs Historic Market Size by Country
        5.1.1 North America Schizophrenia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Schizophrenia Drugs Sales in Volume by Country (2018-2023)
        5.1.3 North America Schizophrenia Drugs Sales in Value by Country (2018-2023)
    5.2 North America Schizophrenia Drugs Forecasted Market Size by Country
        5.2.1 North America Schizophrenia Drugs Sales in Volume by Country (2024-2029)
        5.2.2 North America Schizophrenia Drugs Sales in Value by Country (2024-2029)

 6 Europe Schizophrenia Drugs by Country
    6.1 Europe Schizophrenia Drugs Historic Market Size by Country
        6.1.1 Europe Schizophrenia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Schizophrenia Drugs Sales in Volume by Country (2018-2023)
        6.1.3 Europe Schizophrenia Drugs Sales in Value by Country (2018-2023)
    6.2 Europe Schizophrenia Drugs Forecasted Market Size by Country
        6.2.1 Europe Schizophrenia Drugs Sales in Volume by Country (2024-2029)
        6.2.2 Europe Schizophrenia Drugs Sales in Value by Country (2024-2029)

 7 Asia-Pacific Schizophrenia Drugs by Region
    7.1 Asia-Pacific Schizophrenia Drugs Historic Market Size by Region
        7.1.1 Asia-Pacific Schizophrenia Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Schizophrenia Drugs Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Schizophrenia Drugs Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Schizophrenia Drugs Forecasted Market Size by Region
        7.2.1 Asia-Pacific Schizophrenia Drugs Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Schizophrenia Drugs Sales in Value by Region (2024-2029)

 8 Latin America Schizophrenia Drugs by Country
    8.1 Latin America Schizophrenia Drugs Historic Market Size by Country
        8.1.1 Latin America Schizophrenia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Schizophrenia Drugs Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Schizophrenia Drugs Sales in Value by Country (2018-2023)
    8.2 Latin America Schizophrenia Drugs Forecasted Market Size by Country
        8.2.1 Latin America Schizophrenia Drugs Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Schizophrenia Drugs Sales in Value by Country (2024-2029)

 9 Middle East and Africa Schizophrenia Drugs by Country
    9.1 Middle East and Africa Schizophrenia Drugs Historic Market Size by Country
        9.1.1 Middle East and Africa Schizophrenia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Schizophrenia Drugs Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Schizophrenia Drugs Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Schizophrenia Drugs Forecasted Market Size by Country
        9.2.1 Middle East and Africa Schizophrenia Drugs Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Schizophrenia Drugs Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Johnson & Johnson
        10.1.1 Johnson & Johnson Company Information
        10.1.2 Johnson & Johnson Introduction and Business Overview
        10.1.3 Johnson & Johnson Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Johnson & Johnson Schizophrenia Drugs Products Offered
        10.1.5 Johnson & Johnson Recent Development
    10.2 Bristol-Myers Squibb
        10.2.1 Bristol-Myers Squibb Company Information
        10.2.2 Bristol-Myers Squibb Introduction and Business Overview
        10.2.3 Bristol-Myers Squibb Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Bristol-Myers Squibb Schizophrenia Drugs Products Offered
        10.2.5 Bristol-Myers Squibb Recent Development
    10.3 Otsuka Pharma
        10.3.1 Otsuka Pharma Company Information
        10.3.2 Otsuka Pharma Introduction and Business Overview
        10.3.3 Otsuka Pharma Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Otsuka Pharma Schizophrenia Drugs Products Offered
        10.3.5 Otsuka Pharma Recent Development
    10.4 AstraZeneca
        10.4.1 AstraZeneca Company Information
        10.4.2 AstraZeneca Introduction and Business Overview
        10.4.3 AstraZeneca Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 AstraZeneca Schizophrenia Drugs Products Offered
        10.4.5 AstraZeneca Recent Development
    10.5 Sumitomo Dainippon
        10.5.1 Sumitomo Dainippon Company Information
        10.5.2 Sumitomo Dainippon Introduction and Business Overview
        10.5.3 Sumitomo Dainippon Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Sumitomo Dainippon Schizophrenia Drugs Products Offered
        10.5.5 Sumitomo Dainippon Recent Development
    10.6 Eli Lilly
        10.6.1 Eli Lilly Company Information
        10.6.2 Eli Lilly Introduction and Business Overview
        10.6.3 Eli Lilly Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Eli Lilly Schizophrenia Drugs Products Offered
        10.6.5 Eli Lilly Recent Development
    10.7 Alkermes
        10.7.1 Alkermes Company Information
        10.7.2 Alkermes Introduction and Business Overview
        10.7.3 Alkermes Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Alkermes Schizophrenia Drugs Products Offered
        10.7.5 Alkermes Recent Development
    10.8 Vanda Pharma
        10.8.1 Vanda Pharma Company Information
        10.8.2 Vanda Pharma Introduction and Business Overview
        10.8.3 Vanda Pharma Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Vanda Pharma Schizophrenia Drugs Products Offered
        10.8.5 Vanda Pharma Recent Development
    10.9 Allergan
        10.9.1 Allergan Company Information
        10.9.2 Allergan Introduction and Business Overview
        10.9.3 Allergan Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.9.4 Allergan Schizophrenia Drugs Products Offered
        10.9.5 Allergan Recent Development
    10.10 Pfizer
        10.10.1 Pfizer Company Information
        10.10.2 Pfizer Introduction and Business Overview
        10.10.3 Pfizer Schizophrenia Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.10.4 Pfizer Schizophrenia Drugs Products Offered
        10.10.5 Pfizer Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Schizophrenia Drugs Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Schizophrenia Drugs Industrial Chain Analysis
    11.4 Schizophrenia Drugs Market Dynamics
        11.4.1 Schizophrenia Drugs Industry Trends
        11.4.2 Schizophrenia Drugs Market Drivers
        11.4.3 Schizophrenia Drugs Market Challenges
        11.4.4 Schizophrenia Drugs Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Schizophrenia Drugs Distributors
    12.3 Schizophrenia Drugs Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Oral Antipsychotics
    Table 2. Major Company of Injectable Antipsychotics
    Table 3. Global Schizophrenia Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Schizophrenia Drugs Sales by Type (2018-2023) & (K Units)
    Table 5. Global Schizophrenia Drugs Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Schizophrenia Drugs Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Schizophrenia Drugs Market Share in Value by Type (2018-2023)
    Table 8. Global Schizophrenia Drugs Price by Type (2018-2023) & (USD/Unit)
    Table 9. Global Schizophrenia Drugs Sales by Type (2024-2029) & (K Units)
    Table 10. Global Schizophrenia Drugs Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Schizophrenia Drugs Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Schizophrenia Drugs Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Schizophrenia Drugs Price by Type (2024-2029) & (USD/Unit)
    Table 14. North America Schizophrenia Drugs Sales by Type (2018-2023) & (K Units)
    Table 15. North America Schizophrenia Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Schizophrenia Drugs Sales (K Units) by Type (2018-2023)
    Table 17. Europe Schizophrenia Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Schizophrenia Drugs Sales (K Units) by Type (2018-2023)
    Table 19. Asia-Pacific Schizophrenia Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Schizophrenia Drugs Sales (K Units) by Type (2018-2023)
    Table 21. Latin America Schizophrenia Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Schizophrenia Drugs Sales (K Units) by Type (2018-2023)
    Table 23. Middle East and Africa Schizophrenia Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Schizophrenia Drugs Sales by Company (2018-2023) & (K Units)
    Table 25. Global Schizophrenia Drugs Sales Share by Company (2018-2023)
    Table 26. Global Schizophrenia Drugs Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Schizophrenia Drugs Revenue Share by Company (2018-2023)
    Table 28. Global Market Schizophrenia Drugs Price by Company (2018-2023) & (USD/Unit)
    Table 29. Global Schizophrenia Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Schizophrenia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Schizophrenia Drugs as of 2022)
    Table 32. Date of Key Manufacturers Enter into Schizophrenia Drugs Market
    Table 33. Key Manufacturers Schizophrenia Drugs Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Schizophrenia Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Schizophrenia Drugs Sales by Region (2018-2023) & (K Units)
    Table 37. Global Schizophrenia Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Schizophrenia Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Schizophrenia Drugs Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Schizophrenia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 41. Global Schizophrenia Drugs Sales by Region (2024-2029) & (K Units)
    Table 42. Global Schizophrenia Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Schizophrenia Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Schizophrenia Drugs Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Schizophrenia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 46. Global Schizophrenia Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Schizophrenia Drugs Sales by Application (2018-2023) & (K Units)
    Table 48. Global Schizophrenia Drugs Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Schizophrenia Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Schizophrenia Drugs Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Schizophrenia Drugs Price by Application (2018-2023) & (USD/Unit)
    Table 52. Global Schizophrenia Drugs Sales by Application (2024-2029) & (K Units)
    Table 53. Global Schizophrenia Drugs Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Schizophrenia Drugs Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Schizophrenia Drugs Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Schizophrenia Drugs Price by Application (2024-2029) & (USD/Unit)
    Table 57. North America Schizophrenia Drugs Sales by Application (2018-2023) (K Units) 
    Table 58. North America Schizophrenia Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Schizophrenia Drugs Sales by Application (2018-2023) (K Units) 
    Table 60. Europe Schizophrenia Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Schizophrenia Drugs Sales by Application (2018-2023) (K Units) 
    Table 62. Asia-Pacific Schizophrenia Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Schizophrenia Drugs Sales by Application (2018-2023) (K Units) 
    Table 64. Latin America Schizophrenia Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Schizophrenia Drugs Sales by Application (2018-2023) (K Units) 
    Table 66. Middle East and Africa Schizophrenia Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Schizophrenia Drugs Sales by Country (2018-2023) & (K Units)
    Table 68. North America Schizophrenia Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Schizophrenia Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Schizophrenia Drugs Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Schizophrenia Drugs Sales by Country (2024-2029) & (K Units)
    Table 72. North America Schizophrenia Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Schizophrenia Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Schizophrenia Drugs Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Schizophrenia Drugs Sales by Country (2018-2023) & (K Units)
    Table 76. Europe Schizophrenia Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Schizophrenia Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Schizophrenia Drugs Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Schizophrenia Drugs Sales by Country (2024-2029) & (K Units)
    Table 80. Europe Schizophrenia Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Schizophrenia Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Schizophrenia Drugs Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Schizophrenia Drugs Sales by Region (2018-2023) & (K Units)
    Table 84. Asia-Pacific Schizophrenia Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Schizophrenia Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Schizophrenia Drugs Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Schizophrenia Drugs Sales by Region (2024-2029) & (K Units)
    Table 88. Asia-Pacific Schizophrenia Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Schizophrenia Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Schizophrenia Drugs Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Schizophrenia Drugs Sales by Country (2018-2023) & (K Units)
    Table 92. Latin America Schizophrenia Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Schizophrenia Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Schizophrenia Drugs Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Schizophrenia Drugs Sales by Country (2024-2029) & (K Units)
    Table 96. Latin America Schizophrenia Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Schizophrenia Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Schizophrenia Drugs Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Schizophrenia Drugs Sales by Country (2018-2023) & (K Units)
    Table 100. Middle East and Africa Schizophrenia Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Schizophrenia Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Schizophrenia Drugs Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Schizophrenia Drugs Sales by Country (2024-2029) & (K Units)
    Table 104. Middle East and Africa Schizophrenia Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Schizophrenia Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Schizophrenia Drugs Sales Market Share in Value by Country (2024-2029)
    Table 107. Johnson & Johnson Company Information
    Table 108. Johnson & Johnson Introduction and Business Overview
    Table 109. Johnson & Johnson Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 110. Johnson & Johnson Schizophrenia Drugs Product
    Table 111. Johnson & Johnson Recent Development
    Table 112. Bristol-Myers Squibb Company Information
    Table 113. Bristol-Myers Squibb Introduction and Business Overview
    Table 114. Bristol-Myers Squibb Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 115. Bristol-Myers Squibb Schizophrenia Drugs Product
    Table 116. Bristol-Myers Squibb Recent Development
    Table 117. Otsuka Pharma Company Information
    Table 118. Otsuka Pharma Introduction and Business Overview
    Table 119. Otsuka Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 120. Otsuka Pharma Schizophrenia Drugs Product
    Table 121. Otsuka Pharma Recent Development
    Table 122. AstraZeneca Company Information
    Table 123. AstraZeneca Introduction and Business Overview
    Table 124. AstraZeneca Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 125. AstraZeneca Schizophrenia Drugs Product
    Table 126. AstraZeneca Recent Development
    Table 127. Sumitomo Dainippon Company Information
    Table 128. Sumitomo Dainippon Introduction and Business Overview
    Table 129. Sumitomo Dainippon Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 130. Sumitomo Dainippon Schizophrenia Drugs Product
    Table 131. Sumitomo Dainippon Recent Development
    Table 132. Eli Lilly Company Information
    Table 133. Eli Lilly Introduction and Business Overview
    Table 134. Eli Lilly Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 135. Eli Lilly Schizophrenia Drugs Product
    Table 136. Eli Lilly Recent Development
    Table 137. Alkermes Company Information
    Table 138. Alkermes Introduction and Business Overview
    Table 139. Alkermes Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 140. Alkermes Schizophrenia Drugs Product
    Table 141. Alkermes Recent Development
    Table 142. Vanda Pharma Company Information
    Table 143. Vanda Pharma Introduction and Business Overview
    Table 144. Vanda Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 145. Vanda Pharma Schizophrenia Drugs Product
    Table 146. Vanda Pharma Recent Development
    Table 147. Allergan Company Information
    Table 148. Allergan Introduction and Business Overview
    Table 149. Allergan Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 150. Allergan Schizophrenia Drugs Product
    Table 151. Allergan Recent Development
    Table 152. Pfizer Company Information
    Table 153. Pfizer Introduction and Business Overview
    Table 154. Pfizer Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 155. Pfizer Schizophrenia Drugs Product
    Table 156. Pfizer Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Schizophrenia Drugs Market Trends
    Table 160. Schizophrenia Drugs Market Drivers
    Table 161. Schizophrenia Drugs Market Challenges
    Table 162. Schizophrenia Drugs Market Restraints
    Table 163. Schizophrenia Drugs Distributors List
    Table 164. Schizophrenia Drugs Downstream Customers
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Schizophrenia Drugs Product Picture
    Figure 2. Global Schizophrenia Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Schizophrenia Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Schizophrenia Drugs Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Oral Antipsychotics
    Figure 6. Global Oral Antipsychotics Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Injectable Antipsychotics
    Figure 8. Global Injectable Antipsychotics Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Global Schizophrenia Drugs Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Schizophrenia Drugs Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Schizophrenia Drugs Sales Market Share in Volume by Type in 2022
    Figure 12. North America Schizophrenia Drugs Sales Market Share in Value by Type in 2022
    Figure 13. Europe Schizophrenia Drugs Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Schizophrenia Drugs Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Schizophrenia Drugs Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Schizophrenia Drugs Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Schizophrenia Drugs Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Schizophrenia Drugs Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Schizophrenia Drugs Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Schizophrenia Drugs Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Schizophrenia Drugs Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Schizophrenia Drugs Revenue in 2022
    Figure 23. Schizophrenia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Hospital
    Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
    Figure 26. Product Picture of Clinic
    Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Global Schizophrenia Drugs Sales by Application (2018-2029) & (US$ Million)
    Figure 29. Global Schizophrenia Drugs Sales Market Share by Application in 2022 & 2029
    Figure 30. North America Schizophrenia Drugs Sales Market Share in Volume by Application in 2022
    Figure 31. North America Schizophrenia Drugs Sales Market Share in Value by Application in 2022
    Figure 32. Europe Schizophrenia Drugs Sales Market Share in Volume by Application in 2022
    Figure 33. Europe Schizophrenia Drugs Sales Market Share in Value by Application in 2022
    Figure 34. Asia-Pacific Schizophrenia Drugs Sales Market Share in Volume by Application in 2022
    Figure 35. Asia-Pacific Schizophrenia Drugs Sales Market Share in Value by Application in 2022
    Figure 36. Latin America Schizophrenia Drugs Sales Market Share in Volume by Application in 2022
    Figure 37. Latin America Schizophrenia Drugs Sales Market Share in Value by Application in 2022
    Figure 38. Middle East and Africa Schizophrenia Drugs Sales Market Share in Value by Application in 2022
    Figure 39. Key Raw Materials Price
    Figure 40. Schizophrenia Drugs Manufacturing Cost Structure
    Figure 41. Schizophrenia Drugs Industrial Chain Analysis
    Figure 42. Channels of Distribution
    Figure 43. Distributors Profiles
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed

Schizophrenia Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Schizophrenia Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Schizophrenia Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. 

Globally, Schizophrenia Drugs key manufacturers include Johnson & Johnson, Bristol-Myers Squibb, Otsuka Pharma, AstraZeneca, Sumitomo Dainippon, Eli Lilly, Alkermes, Vanda Pharma and Allergan, etc. Johnson & Johnson, Bristol-Myers Squibb, Otsuka Pharma are top 3 players and held % sales share in total in 2022.

Schizophrenia Drugs can be divided into Oral Antipsychotics and Injectable Antipsychotics, etc. Oral Antipsychotics is the mainstream product in the market, accounting for % sales share globally in 2022.

Schizophrenia Drugs is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Schizophrenia Drugs industry development. In 2022, global % sales of Schizophrenia Drugs went into Hospital filed. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Schizophrenia Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    Johnson & Johnson
    Bristol-Myers Squibb
    Otsuka Pharma
    AstraZeneca
    Sumitomo Dainippon
    Eli Lilly
    Alkermes
    Vanda Pharma
    Allergan
    Pfizer

Segment by Type
    Oral Antipsychotics
    Injectable Antipsychotics

Segment by Application
    Hospital
    Clinic

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Schizophrenia Drugs market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Schizophrenia Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Schizophrenia Drugs industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Schizophrenia Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Schizophrenia Drugs introduction, etc. Schizophrenia Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Schizophrenia Drugs market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.